CoreAge Rx vs CaliberRx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and CaliberRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 58 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make CaliberRx a bad call — it's best for people seeking self-pay telehealth who obtain a complete itemized quote and verify the actual clinical practice, medication and state access. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | CaliberRx |
|---|---|---|
| Brief Score | 94/100 (A) | 58/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Complete selected-plan quote unconfirmed Membership excludes medication and clinical consultations. Exact semaglutide preparation, pharmacy supply and full initial/renewal amount unconfirmed; excludes AL/MA/RI/VT. Started membership cycles generally nonrefundable; cancel at least 48 hours ahead as recommended. Completed consults final; under-24-hour/no-show appointment may cost $30. Pharmacy refunds depend on fulfillment. Full price detailsSemaglutide care advertised; exact preparation and complete selected-prescription quote unknown; membership, clinical consultation and dispensing-pharmacy medication charges are separate categories without a complete public selected-plan price |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Medication panel $199/mo; total unconfirmed Compounded tirzepatide; selected quantity unconfirmed. Membership excludes medication and consultations, so obtain full itemized initial/renewal quote; excludes AL/MA/RI/VT. Started membership cycles generally nonrefundable; cancel at least 48 hours ahead as recommended. Pharmacy cancellation refund only if fulfillment can be stopped; damage/temperature concerns within 48 hours. Full price detailsCompounded tirzepatide care advertised; complete selected-prescription quote unknown; product panel displays $199/month, while membership, clinician and dispensing-pharmacy charges are separately described and full supply unconfirmed |
| Coverage | US only; restrictions by state, confirmed at intake | Legal footer lists 46 states plus Washington DC, excluding Alabama, Massachusetts, Rhode Island and Vermont; individual provider/pharmacy eligibility applies |
| Brand-name access | Not confirmed | The reviewed current offer does not establish a named branded GLP-1 prescription; verify the actual preparation with the clinician and pharmacy. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
CaliberRx: Full quote unconfirmed; membership, clinician and pharmacy charges separate. Tirzepatide panel $199/month is not an all-in amount. Four states excluded; cancel early for renewal, with charge-specific refund rules.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.